Market Update: S&W Seed Company (SANW), Achillion Pharmaceuticals, Inc. (ACHN), Uranium Resources, Inc. (URRE)

Putnam Investments reduced its exposure to the equity of S&W Seed Company (NASDAQ:SANW). The privately-owned investment management firm lowered its equity stake in the company to 309,375 shares from about 1.2 million shares. The Street Insider reported that the new position represents 2.7% of the outstanding shares of S&W Seed Company (NASDAQ:SANW).

On quarterly performance, S&W Seed Company (NASDAQ:SANW) reported earnings of $0.05 per share in the most recent quarter. That was short of the expected earnings of $0.08 per share. Revenue for the quarter came in at $19.60 million.

A number of analysts have recently commented on the stock of S&W Seed Company (NASDAQ:SANW). Zacks rates the stock as an “Outperform” with a target price of $8.

Do analyst foresee a double-top for SANW?

Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) reported positive study results from a trial that combined its hepatitis C investigational drug, ACH-3102 and Sovaldi. The company said that all the 12 patients involved in the trial responded positively to the treatment without showing side effects. Fox Business stated in an article that the study spanned eight weeks after which there were no detectable levels of the virus in the body of the patients.

Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) is also trying other treatments for hepatitis C and next year it has plans to try three drugs for the condition. It will try a cocktail of drugs that include ACH-3102, ACH-3422 and sovaprevir.

Sovaldi is a blockbuster drug marketed by Gilead Sciences, Inc. (NASDAQ:GILD). The treatment was approved in 2013.

Are expert analyst predicting a future consolidation of ACHN?

Uranium Resources, Inc. (NASDAQ:URRE) started the week on a positive note as at least one analyst cited that uranium spot prices could increase. The Street Insider pointed out in article published on its website that the price for the commodity was expected to reach higher than $50 per lb over the next 12 months. The optimism is drawn from the reports about possible restart of two nuclear reactors in Japan. The restart of the reactors is expected to ease the pressure on the market.

Uranium Resources, Inc. (NASDAQ:URRE) gained nearly 32% on an extremely huge volume on the basis of the upbeat report.

Expert breakdown of the URRE candlestick chart.

About the Author

Michael joined US Markets Daily in 2009 and is a national news reporter focusing on economic issues, data analysis and the financial health of state and local governments.

Leave A Response